- Home
- AGS vs TRML Comparison
AGS vs TRML Comparison
Compare AGS & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGS
- TRML
- Stock Information
- Founded
- AGS 2005
- TRML 2021
- Country
- AGS United States
- TRML United States
- Employees
- AGS N/A
- TRML N/A
- Industry
- AGS Miscellaneous manufacturing industries
- TRML Biotechnology: Pharmaceutical Preparations
- Sector
- AGS Consumer Discretionary
- TRML Health Care
- Exchange
- AGS Nasdaq
- TRML Nasdaq
- Market Cap
- AGS 500.5M
- TRML 509.8M
- IPO Year
- AGS 2018
- TRML N/A
- Fundamental
- Price
- AGS $12.09
- TRML $14.45
- Analyst Decision
- AGS Hold
- TRML Strong Buy
- Analyst Count
- AGS 4
- TRML 6
- Target Price
- AGS $12.63
- TRML $45.20
- AVG Volume (30 Days)
- AGS 378.3K
- TRML 356.2K
- Earning Date
- AGS 03-06-2025
- TRML 03-13-2025
- Dividend Yield
- AGS N/A
- TRML N/A
- EPS Growth
- AGS 11887.21
- TRML N/A
- EPS
- AGS 1.20
- TRML N/A
- Revenue
- AGS $394,865,000.00
- TRML N/A
- Revenue This Year
- AGS $4.57
- TRML $363.93
- Revenue Next Year
- AGS $5.14
- TRML N/A
- P/E Ratio
- AGS $10.10
- TRML N/A
- Revenue Growth
- AGS 10.75
- TRML N/A
- 52 Week Low
- AGS $8.23
- TRML $11.87
- 52 Week High
- AGS $12.16
- TRML $29.79
- Technical
- Relative Strength Index (RSI)
- AGS 51.05
- TRML 41.51
- Support Level
- AGS $12.08
- TRML $16.39
- Resistance Level
- AGS $12.16
- TRML $17.36
- Average True Range (ATR)
- AGS 0.04
- TRML 1.03
- MACD
- AGS -0.00
- TRML -0.21
- Stochastic Oscillator
- AGS 70.21
- TRML 3.46
About AGS PlayAGS Inc.
PlayAGS Inc is a designer and supplier of gaming products and services for the gaming industry. The company mainly supplies electronic gaming machines (EGM), server-based systems and back-office systems which are used by casinos, and various gaming locations. Its operating segments are EGM, Table Products, and Interactive. The EGM segment offers a selection of video slot titles developed for the world-wide marketplace as well as EGM cabinets. Its Table Products segments include live proprietary table games and side bets, as well as ancillary table products. The Interactive segment consists of delivering games through mobile apps such as Lucky Play Casino and Vegas Fever. It earns a majority of its revenue from Electronic Gaming Machines segment and geographically from the United States.
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.